阿巴塔克普
医学
类风湿性关节炎
托法替尼
Janus激酶抑制剂
贾纳斯激酶
抗风湿药
关节炎
药理学
内科学
美罗华
受体
淋巴瘤
作者
Andrea Rubbert-Roth,Jeffrey Enejosa,Aileen L. Pangan,Boulos Haraoui,Maureen Rischmueller,N. Khan,Ying Zhang,Naomi Martin,Ricardo Machado Xavier
标识
DOI:10.1056/nejmoa2008250
摘要
Upadacitinib is an oral selective Janus kinase inhibitor to treat rheumatoid arthritis. The efficacy and safety of upadacitinib as compared with abatacept, a T-cell costimulation modulator, in patients with rheumatoid arthritis refractory to biologic disease-modifying antirheumatic drugs (DMARDs) are unclear.
科研通智能强力驱动
Strongly Powered by AbleSci AI